Replies to post #256562 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

Thanks Jager997.
IR

Although not likely June since we are at the end of the month. The data is locked but it will take some time to analyze and review the data.

This is about what I expected right now but am tired of the delays along w/others. I know these are not your dates/numbers...EXCELLENT WORK..DANKE SEHR

[tradeherpete]

Jager – I expected to hear approval of some kind from the Australian Government by now.
IR – They are waiting on test results from the studies.

Really?

I’ve thought that but it’s nice, (mind blowing) to hear it’s true.

[TempePhil]

Jager, thanks for the IR update.
Good to get a response on the Australian gov situation.

[McMagyar]

Thanks jager

[jimmy_mcyoloswag]

Highlighting this sentence so that everybody can adjust their expectations accordingly:


“IR – I don’t have an exact date but sometime this summer, June, July, or AUGUST. Although not likely June since we are at the end of the month. The data is locked but it will take some time to analyze and review the data.”

My hope is July but if they want to do a deep dive then August it is..

[Amatuer17]

Hager - thanks for the update. So PDD results now late Jul to Aug.

With no near catalyst - does the stock go back to $3.50 to $4.0 range?

[baltimorebullet]

I may have missed this revelation earlier but this statement would seems to be the big news:

" We feel that we can take Rett Syndrome and Parkinson’s treatment to market ".

Didn't we previously think we could only do Rett alone?

[Pazzo1212]

I’m just going to expect the end of August as not to create any unnecessary expectations and therefore disappointment. Especially when I have no idea what’s happening behind the scenes. Anything before that will be a great surprise.

[tootalljones]

outstanding post Jager.

[anders2211]

Thank you Jager,

Very exciting indeed!

[georgejjl]

Jager – Back some time ago I recall Dr. Missling mentioning you would probably partner going into large scale trial with Alzheimer, phase three study… Is that still on the table?


IR – We want to maintain good value to our shareholders. If we partner with someone part of the proceeds will have to go to the partner. We feel that we can take Rett Syndrome and Parkinson’s treatment to market but would probably need to partner with a manufacturer to meet Alzheimer treatment.

Good luck and GOD bless,